rs1553512642
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_001875.5(CPS1):c.1760G>A(p.Arg587His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000753 in 1,460,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R587L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001875.5 missense
Scores
Clinical Significance
Conservation
Publications
- carbamoyl phosphate synthetase I deficiency diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CPS1 | NM_001875.5 | c.1760G>A | p.Arg587His | missense_variant | Exon 16 of 38 | ENST00000233072.10 | NP_001866.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CPS1 | ENST00000233072.10 | c.1760G>A | p.Arg587His | missense_variant | Exon 16 of 38 | 1 | NM_001875.5 | ENSP00000233072.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460526Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 726600 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Congenital hyperammonemia, type I Pathogenic:3
Variant summary: CPS1 c.1760G>A (p.Arg587His) results in a non-conservative amino acid change located in the Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain (IPR005479) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250578 control chromosomes (gnomAD). c.1760G>A has been reported in the literature in individuals affected with Carbamoylphosphate Synthetase I Deficiency, including one homozygote (Summar_1998, Kurokawa_2007, Wang_2010, Fan_2019). These data indicate that the variant is likely to be associated with disease. At least one functional study reports this variant affects the residue of the catalytic site and has been shown to practically abolished enzyme activity by blocking carbamate synthesis (Yefimenko_2005). Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic and likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 587 of the CPS1 protein (p.Arg587His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with carbamoyl phosphate synthetase I deficiency (PMID: 9686343, 20855223, 27150549, 31749211). ClinVar contains an entry for this variant (Variation ID: 549934). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CPS1 protein function. Experimental studies have shown that this missense change affects CPS1 function (PMID: 15876373). For these reasons, this variant has been classified as Pathogenic. -
Pulmonary hypertension, neonatal, susceptibility to;C4082171:Congenital hyperammonemia, type I Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at